| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Larimar Therapeutics Inc (NASDAQ: LRMR)
LRMR Technical Analysis
4
| As on 9th Jun 2023 LRMR STOCK Price closed @ 3.65 and we RECOMMEND Sell for LONG-TERM with Stoploss of 4.16 & Strong Sell for SHORT-TERM with Stoploss of 8.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LRMRSTOCK Price
| Open | 3.63 | Change | Price | % |
| High | 3.71 | 1 Day | 0.14 | 3.99 |
| Low | 3.49 | 1 Week | -0.11 | -2.93 |
| Close | 3.65 | 1 Month | -0.86 | -19.07 |
| Volume | 225900 | 1 Year | -7.35 | -66.82 |
| 52 Week High 11.00 | 52 Week Low 1.53 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LRMR Daily Charts |
LRMR Intraday Charts |
Whats New @ Bazaartrend |
LRMR Free Analysis |
|
|
LRMR Important Levels Intraday
| RESISTANCE | 4.07 |
| RESISTANCE | 3.94 |
| RESISTANCE | 3.85 |
| RESISTANCE | 3.77 |
| SUPPORT | 3.53 |
| SUPPORT | 3.45 |
| SUPPORT | 3.36 |
| SUPPORT | 3.23 |
LRMR Forecast April 2024
| 4th UP Forecast | 19.72 |
| 3rd UP Forecast | 14.57 |
| 2nd UP Forecast | 11.38 |
| 1st UP Forecast | 8.2 |
| 1st DOWN Forecast | -0.9 |
| 2nd DOWN Forecast | -4.08 |
| 3rd DOWN Forecast | -7.27 |
| 4th DOWN Forecast | -12.42 |
LRMR Weekly Forecast
| 4th UP Forecast | 6.39 |
| 3rd UP Forecast | 5.51 |
| 2nd UP Forecast | 4.97 |
| 1st UP Forecast | 4.42 |
| 1st DOWN Forecast | 2.88 |
| 2nd DOWN Forecast | 2.33 |
| 3rd DOWN Forecast | 1.79 |
| 4th DOWN Forecast | 0.91 |
LRMR Forecast2024
| 4th UP Forecast | 22.5 |
| 3rd UP Forecast | 16.45 |
| 2nd UP Forecast | 12.72 |
| 1st UP Forecast | 8.98 |
| 1st DOWN Forecast | -1.68 |
| 2nd DOWN Forecast | -5.42 |
| 3rd DOWN Forecast | -9.15 |
| 4th DOWN Forecast | -15.2 |
Larimar Therapeutics Inc ( NASDAQ USA Symbol : LRMR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LRMR Business Profile
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases. The company's lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare and progressive genetic disease. Larimar Therapeutics, Inc. is headquartered in Bala Cynwyd, Pennsylvania. Address: Three Bala Plaza East, Bala Cynwyd, PA, United States, 19004
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service